Therapeutic effects of anti-amyloid β antibody after intravenous injection and efficient nose-to-brain delivery in Alzheimer’s disease mouse model-Reference-Cited by-同舟云学术

Therapeutic effects of anti-amyloid β antibody after intravenous injection and efficient nose-to-brain delivery in Alzheimer’s disease mouse model

Published:2022-01-11 Issue:11 Volume:12 Page:2667-2677
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Kamei Noriyasu^ORCID,Hashimoto Ayaka,Tanaka Erina,Murata Kaho,Yamaguchi Maika,Yokoyama Natsuki,Kato Masahiro,Oki Keisuke,Saito Takashi,Saido Takaomi C.,Takeda-Morishita Mariko

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1007/s13346-022-01117-6.pdf

Reference40 articles.

1. Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016;8(6):595–608. https://doi.org/10.15252/emmm.201606210.

2. Cline EN, Bicca MA, Viola KL, Klein WL. The Amyloid-beta Oligomer Hypothesis: Beginning of the Third Decade. J Alzheimers Dis. 2018;64(s1):S567–610. https://doi.org/10.3233/JAD-179941.

3. Mehta D, Jackson R, Paul G, Shi J, Sabbagh M. Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010–2015. Expert Opin Investig Drugs. 2017. https://doi.org/10.1080/13543784.2017.1323868.

4. Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, et al. Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease. N Engl J Med. 2018;378(4):321–30. https://doi.org/10.1056/NEJMoa1705971.

5. Abushouk A, Elmaraezy A, Aglan A, Salama R, Fouda S, Fouda R, et al. Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials. BMC Neurol. 2017;17(1):66. https://doi.org/10.1186/s12883-017-0850-1.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-Penetrating Peptides-Mediated Therapeutic Agents Delivery into the Central Nervous System;ACS Materials Letters;2024-05-09

2. Applications of App and MAPT knock-in mice to understanding disease mechanisms;Alzheimer' s Disease Research Guide;2024

3. Development of Efficient Nose-to-Brain Delivery Technology for Treatment of Dementia with Biological Drugs;Drug Delivery System;2023-03-25

4. Targeting Specific Barriers;CPP, Cell-Penetrating Peptides;2023